FDA Approves Unknown Drug — ACCORD HLTHCARE

# FDA Approves ANDA Submission for Accord Healthcare Accord Healthcare has received FDA approval for its abbreviated new drug application (ANDA206058), expanding the company's generic drug portfolio and positioning it to capture additional market share in the competitive generic pharmaceuticals sector. The approval strengthens Accord's ability to meet growing demand for cost-effective therapeutic alternatives in the U.S. market.